Adhera Therapeutics, Inc. announced the appointment of Trond K. Waerness as Chairman of the Company's Board of Directors. Mr. Waerness has been serving as a Director at Adhera since April 2021. Mr. Waerness is assuming the role of Chairman, replacing Andrew Kucharchuk, who will remain Chief Executive Officer and Vice-Chairman.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0045 USD | -25.00% | 0.00% | -85.00% |
1st Jan change | Capi. | |
---|---|---|
-85.00% | 52.32K | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.43% | 22.1B | |
-8.91% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ATRX Stock
- News Adhera Therapeutics, Inc.
- Adhera Therapeutics, Inc. Appoints Trond K. Waerness as Chairman of the Board